CClinicalTrials.gg
CompletedNCT00662753Updated Feb 25, 2016

A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure

A Phase 1 interventional study of Home monitoring and monitor & phone call in Hypertension, sponsored by George Washington University. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-02-25.

Sponsored by George Washington University · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to determine if the use of home blood pressure monitors plus nurse telephone monitoring is more effective than the use of blood pressure monitors alone in improving control of high blood pressure in an urban medical clinic.

Read the detailed description

Participants will all have home blood pressure monitors, education session on controlling their blood pressure and will be randomized to recieve 6 months of intensive telephonic on a set monitoring schedule or no telephonic follow up. Phone calls will be weekly for 4 weeks, then every 2 weeks for 8 weeks then monthly for 3 months.

02

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • hypertension
  • home blood pressure monitoring
  • nurse telephone follow up
  • medically underserved populations
03

In context

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 111 is above the median of 90 across 4,995 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

George Washington University is the lead sponsor of 187 studies on the registry; 34 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 11 (85%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosed with essential hypertension
  • systolic blood pressure >140 mm Hg (130 if diabetic) OR diastolic blood pressure > 90 mm Hg (80 if diabetic)on at least 2 clinic visits prior to randomization
  • BP at time of screening is > than systolic 140 (130 if diabetic) or diastolic 90 (80 if diabetic)
  • patient is prescribed at least 1 antihypertensive medication
  • Patient is fluent in English
  • Patient is easily accessible by telephone

Exclusion criteria

Exclusion Criteria:

  • persons with stage 4 or 5 chronic kidney disease or end stage renal disease on dialysis
  • Patients with a terminal illness
  • Patients with severe dementia or serious mental illness
  • Inability to preform self blood pressure monitoring
  • Patient lacks a functioning home phone or personal cellular phone
  • Pregnant or planning to get pregnant
  • Arm circumference exceeds the allowable limit on the largest home BP monitor cuff
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
111 participants (actual)

Study arms

  • Active comparator
    home monitoring

    home blood pressure monitor

    Device: Home monitoring

  • Experimental
    monitor & phone call

    home blood pressure monitor + phone calls

    Other: monitor & phone call

Interventions

  • DeviceHome monitoring

    Participants will receive a home blood pressure monitor and be taught how to use it. They will have an education session to review treatment goals, medications, diet and exercise. They will be asked to see their primary care provider at least every 3 months and the research nurse at 3, 6 and 12 months.

  • Othermonitor & phone call

    Participants will receive all of the same interventions of the home monitoring group plus they will receive scheduled telephone follow up by the research nurse

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Time frame: at 6 mo and 12 mo after randomization

Secondary outcomes

  1. Blood pressure measured at home

    Time frame: 6 and 12 months post randomization

  2. Compliance with use of home blood pressure monitor

    Time frame: 6 and 12 months post randomization

  3. Number and type of antihypertensives prescribed

    Time frame: 12 months post randomization

  4. Patient satisfaction and Quality of Life

    Time frame: 6 and 12 months post randomization

  5. Primary care provider satisfaction with intervention

    Time frame: 6 mo post randomization of a provider's first patient to enroll in the trial

  6. Number of primary care provider visits

    Time frame: 12 months post randomization

  7. Number and quality of adverse events

    Time frame: 3, 6, and 12 months post randomization

  8. cost analysis

    Time frame: 12 months post randomization

07

Study locations

2 sites
  • Brentwood Unity Health Care Center
    Washington, District of Columbia 20018, United States
  • Congress Heights Unity Health Care Center
    Washington, District of Columbia 20032, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00662753
Lead sponsor
George Washington University
Responsible party
Sponsor
First posted
Apr 21, 2008
Start date
Apr 2008
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Feb 25, 2016

Study contacts

Samir Patel, MD
principal investigator · The George Washington University Medical Faculty Associates
Richard Katz, MD
principal investigator · The George Washington University Medical Faculty Associates

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion